Ambey Laborator.

{
  "main_header": {
    "sid": 10039310,
    "name": "Ambey Laborator.",
    "stock_name": "Ambey Laborator.",
    "full_name": "Ambey Laboratories Ltd",
    "name_url": "stocks-analysis/ambey-laborator",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "30.00",
    "chg": 0.3,
    "chgp": "1.01%",
    "dir": 1,
    "prev_price": "29.70",
    "mcapval": "70.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "AMBEY",
    "ind_name": "Pesticides & Agrochemicals",
    "ind_code": 18,
    "indexname": "",
    "isin": "INE0M3I01029",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": 10000,
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ambey-laborator-10039310-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Ambey Laborator.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-ambey-laborator-3704345",
        "imagepath": "",
        "date": "2025-11-15 00:35:05",
        "description": "Answer:\nThe historical performance of Ambey Laborator shows a steady growth in net sales and total operating income over the past four years, with figures rising from 84.60 Cr in Mar'22 to 131.27 Cr in Mar'25. The total expenditure has also increased, reflecting higher raw material costs, which rose from 69.91 Cr in Mar'22 to 118.83 Cr in Mar'25. Operating profit, excluding other income, has fluctuated slightly, peaking at 11.50 Cr in Mar'25, while profit before tax increased to 6.04 Cr in the same period. However, profit after tax saw a decline to 4.78 Cr in Mar'25 from 7.72 Cr in Mar'24. The company's equity capital has grown significantly, reaching 24.95 Cr in Mar'25, and total liabilities increased to 125.79 Cr, driven by a rise in short-term borrowings. Cash flow from operating activities has been negative, indicating challenges in cash generation, while cash flow from financing activities has provided..."
      },
      {
        "title": "Why is Ambey Laborator. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-ambey-laborator-fallingrising-3703778",
        "imagepath": "",
        "date": "2025-11-15 00:13:07",
        "description": "As of 14-Nov, Ambey Laboratories Ltd is experiencing a price increase, currently at 43.25, which reflects a rise of 3.3 or 8.26%. The stock has shown strong performance today, outperforming its sector by 8.78%. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. The delivery volume has significantly increased by 130.77% compared to the 5-day average, suggesting rising investor participation. However, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nIn the broader market context, Ambey Laboratories Ltd has outperformed the Sensex in the short term, with a 1-week return of +12.05% compared to the Sensex's +1.64%. Despite this short-term strength, the stock has underperformed over longer periods, with a year-to-date decline of -32.16% against the Sensex's ..."
      },
      {
        "title": "Why is Ambey Laborator. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-ambey-laborator-fallingrising-3695389",
        "imagepath": "",
        "date": "2025-11-13 00:22:30",
        "description": "As of 12-Nov, Ambey Laboratories Ltd is experiencing a decline in its stock price, currently at 36.95, reflecting a decrease of 1.6 or 4.15%. The stock has underperformed its sector by 2.75% today, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 74.58% compared to the 5-day average. Over the past week, the stock has decreased by 5.26%, and it has seen a substantial decline of 42.04% year-to-date, indicating ongoing challenges for the company.\n\nIn contrast, the broader market, represented by the Sensex, has shown positive movement, gaining 1.09% over the past week and 9.44% year-to-date. This stark difference highlights that while the market is performing well, Ambey Laboratories Ltd is struggling significantly, with its one-month return at -13.06% compared to th..."
      }
    ],
    "total": 156,
    "sid": "10039310",
    "stock_news_url": "https://www.marketsmojo.com/news/ambey-laboratories-10039310"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

How has been the historical performance of Ambey Laborator.?

2025-11-15 00:35:05

Answer: The historical performance of Ambey Laborator shows a steady growth in net sales and total operating income over the past four years, with figures rising from 84.60 Cr in Mar'22 to 131.27 Cr in Mar'25. The total expenditure has also increased, reflecting higher raw material costs, which rose from 69.91 Cr in Mar'22 to 118.83 Cr in Mar'25. Operating profit, excluding other income, has fluctuated slightly, peaking at 11.50 Cr in Mar'25, while profit before tax increased to 6.04 Cr in the same period. However, profit after tax saw a decline to 4.78 Cr in Mar'25 from 7.72 Cr in Mar'24. The company's equity capital has grown significantly, reaching 24.95 Cr in Mar'25, and total liabilities increased to 125.79 Cr, driven by a rise in short-term borrowings. Cash flow from operating activities has been negative, indicating challenges in cash generation, while cash flow from financing activities has provided...

Read full news article

Why is Ambey Laborator. falling/rising?

2025-11-15 00:13:07

As of 14-Nov, Ambey Laboratories Ltd is experiencing a price increase, currently at 43.25, which reflects a rise of 3.3 or 8.26%. The stock has shown strong performance today, outperforming its sector by 8.78%. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. The delivery volume has significantly increased by 130.77% compared to the 5-day average, suggesting rising investor participation. However, there is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, Ambey Laboratories Ltd has outperformed the Sensex in the short term, with a 1-week return of +12.05% compared to the Sensex's +1.64%. Despite this short-term strength, the stock has underperformed over longer periods, with a year-to-date decline of -32.16% against the Sensex's ...

Read full news article

Why is Ambey Laborator. falling/rising?

2025-11-13 00:22:30

As of 12-Nov, Ambey Laboratories Ltd is experiencing a decline in its stock price, currently at 36.95, reflecting a decrease of 1.6 or 4.15%. The stock has underperformed its sector by 2.75% today, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 74.58% compared to the 5-day average. Over the past week, the stock has decreased by 5.26%, and it has seen a substantial decline of 42.04% year-to-date, indicating ongoing challenges for the company. In contrast, the broader market, represented by the Sensex, has shown positive movement, gaining 1.09% over the past week and 9.44% year-to-date. This stark difference highlights that while the market is performing well, Ambey Laboratories Ltd is struggling significantly, with its one-month return at -13.06% compared to th...

Read full news article

View All News